RGT 0.00% 28.5¢ argent biopharma limited

Ann: Material Revenues Confirmed from Non-Pharma Business Units, page-104

  1. 972 Posts.
    lightbulb Created with Sketch. 107
    Of course revenue is good, that ten fold and we may be able to break even. It doesn't mean much still without the valuation of CG. As for solely MM, I don't see much revenue from that so we will wait and see. Mabsut is BS, was touted as 1m last year and I bet we don't see that in three.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.